Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

EIGR - Eiger BioPharmaceuticals, Inc.

Close
1.725
-0.175   -10.145%

Share volume: 137,824
Last Updated: Wed 10 Apr 2024 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology): -1.15%

PREVIOUS CLOSE
CHG
CHG%
$1.90
-0.18
-9.21%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Income statement Balance sheet Cash flow To see more then 2 years history Buy Premium
View ratios

Fiscal Date 2022-03-31 2022-06-30 2022-09-30 2022-12-31 2023-03-31 2023-06-30 2023-09-30
Fiscal Quarter Q1 2022 Q2 2022 Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023
Report Date 2022-05-05 2022-08-04 2022-11-03 2023-03-17 2023-05-11 2023-08-14 2023-11-09
Total revenue 2.673 M 4.091 M 4.024 M 2.696 M 4.118 M 4.643 M 3.209 M
Cost of revenue 110.000 K 151.000 K 1.231 M 345.000 K 118.000 K -310.000 K 115.000 K
Gross profit 2.563 M 3.940 M 2.793 M 2.351 M 4.000 M 4.953 M 3.094 M
    53.73% -29.11% -15.83% 70.14% 23.83% -37.53%  
Operating expenses 24.383 M 24.020 M 29.162 M 26.822 M 26.263 M 24.934 M 20.022 M
Selling general and admin 6.813 M 7.027 M 6.964 M 8.301 M 9.515 M 5.533 M 5.454 M
Research and development 17.570 M 16.993 M 22.198 M 18.521 M 16.748 M 19.401 M 14.568 M
Total expenses 24.493 M 24.171 M 30.393 M 27.167 M 26.381 M 24.624 M 20.137 M
    -1.31% 25.74% -10.61% -2.89% -6.66% -18.22%  
Operating income -21.820 M -20.080 M -26.369 M -24.471 M -22.263 M -19.981 M -16.928 M
Ebit -21.820 M -20.080 M -26.369 M -24.471 M -22.263 M -19.981 M -16.928 M
Pretax income -22.634 M -21.867 M -27.111 M -25.141 M -22.782 M -20.693 M -18.030 M
    -3.39% 23.98% -7.27% -9.38% -9.17% -12.87%  
Income tax 9.000 K 17.000 K 0.000 -3.000 K 2.000 K 2.000 K 0.000
Net income basic -22.643 M -21.884 M -27.111 M -25.138 M -22.784 M -20.695 M -18.030 M
    3.35% -23.89% 7.28% 9.36% 9.17% 12.88%  
Net income -22.643 M -21.884 M -27.111 M -25.138 M -22.784 M -20.695 M -18.030 M
    3.35% -23.89% 7.28% 9.36% 9.17% 12.88%